Table 3.
Association between NAT1*10 and risk of NHL and NHL subtypes.
| NAT1*any(except *10)/*any(except *10) | NAT1*10/*any(except *10) | NAT1*10/*10 | NAT1*10/any(except *10) | NAT1*10/*10 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| N(%) | OR(95% CI)* | N(%) | OR(95% CI)* | p | N(%) | OR(95% CI)* | p | p for linear trend | N(%) | OR(95% CI)* | p | |
| Controls | 454(60.9) | 251(33.6) | 41(5.5) | 292(39.1) | ||||||||
| All NHL | 547(59.7) | 1.00 (reference) | 303(33.1) | 1.07 (0.87, 1.33) | 0.5 | 66(7.2) | 1.60 (1.04, 2.46) | 0.03 | 0.07 | 369(40.3) | 1.14 (0.92, 1.40) | 0.2 |
| By NHL subtype | ||||||||||||
| DLBCL | 167(57.4) | 1.00 (reference) | 106(36.4) | 1.25 (0.93, 1.68) | 0.1 | 18(6.2) | 1.49 (0.81, 2.74) | 0.2 | 0.08 | 124(42.6) | 1.28 (0.96, 1.70) | 0.09 |
| Follicular lymphoma | 138(63.9) | 1.00 (reference) | 59(27.3) | 0.87 (0.62, 1.24) | 0.5 | 19(8.8) | 2.06 (1.12, 3.79) | 0.02 | 0.3 | 78(36.1) | 1.01 (0.73, 1.40) | 0.9 |
| SLL | 71(59.7) | 1.00 (reference) | 43(36.1) | 1.21 (0.79, 1.84) | 0.4 | 5(4.2) | 0.96 (0.36, 2.57) | 0.9 | 0.6 | 48(40.3) | 1.18 (0.79, 1.77) | 0.4 |
| Marginal zone | 41(57.7) | 1.00 (reference) | 25(35.2) | 1.08 (0.64, 1.84) | 0.8 | 5(7.0) | 1.51 (0.55, 4.17) | 0.4 | 0.5 | 30(42.3) | 1.13 (0.68, 1.88) | 0.6 |
| All T-cell | 33(61.1) | 1.00 (reference) | 16(29.6) | 0.93 (0.49, 1.76) | 0.8 | 5(9.3) | 1.84 (0.64, 5.27) | 0.3 | 0.6 | 21(38.9) | 1.04 (0.58, 1.89) | 0.9 |
*
OR (95% CI) adjusted for age, sex, race, and study center.